FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/10/2023
Voltar para busca
Dado oficial do USPTO
EUROAPI ACTIVE SOLUTIONS FOR HEALTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
10/10/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 40, 42
Data de depósito
23/07/2021
Data de registro
13/06/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/06/2023
Última transação
13/06/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
FR
Examinador
HOWARD, PARKER
Unidade examinadora
N90
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording EUROAPI; below is the stylized wording ACTIVE SOLUTIONS FOR HEALTH.
Titulares e representantes
Titulares
EUROAPI
SANOFI
Representantes
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industryresearch and science; bio-organic products in the nature of biochemical preparation for use in industryresearch and science; active chemical and bio-organic ingredients in the nature of biochemical preparation for use in industryresearch and science
Classe 5
Pharmaceutical preparations for the treatment of cardiovascular diseasescentral and peripheral nervous system diseasesrespiratory diseasescancerallergiesgynecological diseasesrheumatic diseasesurological diseasesgastroenterological diseasesinfectious diseaseseye diseasedermatological diseasesautoimmune diseasesblood diseasesgenital diseasesendocrine diseasesintestinal diseasesinternal medicine diseases; metabolic diseasespsychiatric disordersmuscular diseases; hygienic products for medicine namely bacterial preparations and disinfectants; dietetic foods for medical or veterinary use; food supplements for humans and animals; disinfectants
Classe 40
Treatment of chemicalscustom manufacture and custom synthesis of pharmaceuticals and active pharmaceutical ingredients; custom manufacture of pharmaceuticals
Classe 42
Research and development services in the field of health and biotechnologynamely research with respect to the development of new active ingredients; research for identifying means of industrial synthesis of pharmaceutical products; conducting of industrial quality studiesnamely scientific study and research in the area of industrial quality; research relating to industrial quality namely scientific research in the area of industrial quality; design and development of methods for analyzing chemicals and pharmaceutical and bio-organic products; development and scientific study of analytical methods to control chemical reactions; research and development services applied in the pharmaceutical and chemical fields belonging to others in the nature of the development of chemical or biochemical synthesis pathways; research and development in the field of pharmaceuticalchemicalagrochemical and industrial processes; scientific and industrial analysis services; scientific analysis services for the identification and physical characterization of chemical molecules; design of development batches or commercial batches for others in the pharmaceutical and chemical fields; formulation and pre-formulation development for pharmaceuticalchemical and agrochemical products; engineering services in the field of formulationevaluationprocessesestimation and projects in the scientific and industrial fieldsthe chemical and pharmaceutical fields; scientific study and research services in the field of industrial safety; conducting chemical surveying with respect to fundamental and industrial technologies especially for chemical and pharmaceutical or organic products and their processing
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/09/2023
FIMP
FINAL DISPOSITION PROCESSED
14/09/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/09/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
13/06/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
13/06/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
24/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/04/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/04/2023
GPNX
NOTIFICATION PROCESSED BY IB
29/03/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/03/2023
PUBO
PUBLISHED FOR OPPOSITION
28/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/03/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/02/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
15/02/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
30/09/2022
GNFR
FINAL REFUSAL E-MAILED
30/09/2022
CNFR
FINAL REFUSAL WRITTEN
30/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/08/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/08/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
19/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/08/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/08/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
10/06/2022
RFNT
REFUSAL PROCESSED BY IB
16/05/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/04/2022
RFRR
REFUSAL PROCESSED BY MPU
21/04/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/03/2022
CNRT
NON-FINAL ACTION WRITTEN
14/03/2022
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
04/03/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/02/2022
CNRT
NON-FINAL ACTION WRITTEN
04/02/2022
DOCK
ASSIGNED TO EXAMINER
02/02/2022
MAFR
APPLICATION FILING RECEIPT MAILED
12/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/11/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/11/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EUROAPI ACTIVE SOLUTIONS FOR HEALTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.